A detailed study on this gene has implicated TYMP in the development of lytic bone lesions in MM, via a mechanism involving activation of PI3K/Akt signalling and increased DNMT3A expression resulting in hypermethylation of RUNX2, osterix, and IRF856. The gene discussed is AKT1; the disease is Miyoshi myopathy.